Vascular endothelial growth factor inhibitors in the treatment of neovascular age-related macular degeneration

Vestnik oftalmologii
I N Dyakov, S K Zyryanov

Abstract

Neovascular age-related macular degeneration (AMD) is the leading cause of vision loss in older patients. An important role in angiogenesis is played by regulatory mechanisms (an increase in the number of proliferating endothelial and stromal cells and morphological alterations in the vascular network) induced by factors from the vascular endothelial growth factor (VEGF) family. Since 2006, the key treatment of neovascular AMD includes agents that inhibit the activity of VEGF. This review covers the effectiveness and safety of the use of anti-VEGF agents in neovascular AMD patients. A comparison is drawn between monoclonal antibody-based therapy and a new drug from the VEGF-Trap group.

References

Sep 23, 2000·Nature·P Carmeliet, R K Jain
Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jocelyn HolashJohn S Rudge
Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Apr 28, 2004·JAMA : the Journal of the American Medical Association·Neil M Bressler
May 12, 2004·Nature Reviews. Drug Discovery·Napoleone FerraraWilliam Novotny
Dec 31, 2004·The New England Journal of Medicine·Evangelos S GragoudasUNKNOWN VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group
Jan 22, 2005·Current Opinion in Genetics & Development·Peter BalukDonald M McDonald
Mar 7, 2006·Nature Reviews. Drug Discovery·Eugene W M NgAnthony P Adamis
Oct 6, 2006·The New England Journal of Medicine·Philip J RosenfeldUNKNOWN MARINA Study Group
Mar 31, 2007·Nature Reviews. Drug Discovery·Judah Folkman
May 1, 2007·Ophthalmology·Sophie J BakriRavinder J Singh
Aug 10, 2007·Journal of the National Cancer Institute·Frank A ScappaticciHerbert Hurwitz
Nov 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·John S RudgeGeorge D Yancopoulos
Sep 4, 2008·Cell and Tissue Research·Yongping Crawford, Napoleone Ferrara
Jul 29, 2009·Nature Reviews. Clinical Oncology·Axel Grothey, Evanthia Galanis
Feb 22, 2011·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Angela M CarneiroFernando M Falcão-Reis
Apr 30, 2011·The New England Journal of Medicine·UNKNOWN CATT Research GroupGlenn J Jaffe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.